Observational studyMedicine2026
Analysis of clinical characteristics of 38 patients with dextrocardia: An observational study.
Observational study in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Dextrocardia is an extremely rare congenital anomaly, and survival into adulthood is exceptionally uncommon. This study aimed to systematically analyze the clinical, imaging, laboratory, and functional characteristics of patients with Dextrocardia to improve understanding of its natural history and prognosis. A retrospective review of 38 patients diagnosed with Dextrocardia at a single center from 2012 to 2025 was conducted. Baseline demographic data, associated anomalies, laboratory parameters, imaging findings, cardiac function assessed by the New York Heart Association (NYHA) classification, and follow-up outcomes were collected and analyzed. Of 38 patients, 21 (55%) were male and 17 (45%) were female; the majority were over 61 years of age (36.8%). All patients had Dextrocardia with the heart located entirely within the right hemithorax and no pericardial defects. Laboratory tests showed mild myocardial stress but preserved systemic homeostasis. Imaging demonstrated that computed tomography (CT) was the predominant diagnostic tool, providing detailed anatomical information, while chest X-radiation (X-ray) and echocardiography served as supplementary modalities. Most patients had preserved or mildly impaired cardiac function, around NYHA Class I-II. During a mean follow-up of 21.9 months, all patients survived without mortality. Dextrocardia without major anomalies may represent a distinct subtype with favorable outcomes. Chest CT is the most valuable imaging modality, and functional assessment is essential for prognosis. These findings broaden the clinical spectrum of Dextrocardia and challenge the traditional view that survival is universally poor.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.